Law360, New York (February 13, 2008, 12:00 AM ET) -- A new study has found that Bayer AG's blood-clotting drug Trasylol, which has been suspected of causing kidney damage and death in some cases, appears to be safe for some heart patients.
The study was published Thursday by a team of British researchers in the United Kingdom-based medical journal The Lancet. It determined that Trasylol, also known as aprotinin, appeared to pose little risk for people undergoing on-pump bypass surgery, in which a machine keeps the patient's heart beating during the operation.
However, the risk of...
Study Says Bayer's Trasylol Safe For Some Patients
To view the full article, take a free trial now.
